In conclusion, this meta-analysis did not find a statistically significant difference between the use of a GnRH antagonist protocol compared with the standard long protocol with respect to CPR and OPR in patients with PCOS undergoing IVF. The gene discussed is GNRH1; the disease is polycystic ovary syndrome.